Related references
Note: Only part of the references are listed.Immune-based combinations for metastatic triple negative breast cancer in clinical trials: current knowledge and therapeutic prospects
Alessandro Rizzo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2022)
Biomarkers for breast cancer immunotherapy: PD-L1, TILs, and beyond
Alessandro Rizzo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2022)
Heterozygous loss of Dip2B enhances tumor growth and metastasis by altering immune microenvironment
Salah Adlat et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
Pembrolizumab and atezolizumab in triple-negative breast cancer
Dorota Kwapisz
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
Daniela Miricescu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Immune MAL2-practice: breast cancer immunoevasion via MHC class I degradation
Devin Dersh et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Immune-based combinations for advanced hepatocellular carcinoma: shaping the direction of first-line therapy
Alessandro Rizzo et al.
FUTURE ONCOLOGY (2021)
Pan-cancer association of HLA gene expression with cancer prognosis and immunotherapy efficacy
Evelien Schaafsma et al.
BRITISH JOURNAL OF CANCER (2021)
Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer
Molly A. Nelson et al.
CANCER AND METASTASIS REVIEWS (2021)
Tumor-infiltrating lymphocytes in the immunotherapy era
Sterre T. Paijens et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
PD-L1 Protein Expression on Both Tumor Cells and Macrophages are Associated with Response to Neoadjuvant Durvalumab with Chemotherapy in Triple-negative Breast Cancer
Fahad Shabbir Ahmed et al.
CLINICAL CANCER RESEARCH (2020)
Global transcriptome study of Dip2B-deficient mouse embryonic lung fibroblast reveals its important roles in cell proliferation and development
Salah Adlat et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Targeted Disruption of Mouse Dip2B Leads to Abnormal Lung Development and Prenatal Lethality
Rajiv Kumar Sah et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Immunotherapy and targeted therapy combinations in metastatic breast cancer
Francisco J. Esteva et al.
LANCET ONCOLOGY (2019)
Application of PD-1 Blockade in Cancer Immunotherapy
Xiaomo Wu et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
The Tumor Microenvironment Innately Modulates Cancer Progression
Dominique C. Hinshaw et al.
CANCER RESEARCH (2019)
NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival
Aura Muntasell et al.
CLINICAL CANCER RESEARCH (2019)
The correlation analysis of miRNAs and target genes in metastasis of cervical squamous cell carcinoma
Jing Zhou et al.
EPIGENOMICS (2018)
Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers
Nicolas Jacquelot et al.
FRONTIERS IN IMMUNOLOGY (2018)
CDK4/6 inhibition triggers anti-tumour immunity
Shom Goel et al.
NATURE (2017)
Landscape of Microsatellite Instability Across 39 Cancer Types
Russell Bonneville et al.
JCO PRECISION ONCOLOGY (2017)
Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy
Nayoung Lee et al.
PATHOLOGY (2016)
Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
H. Raza Ali et al.
PLOS MEDICINE (2016)
Clinical significance of tumor-infiltrating lymphocytes in breast cancer
Sasha E. Stanton et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Identification of candidate susceptibility genes for colorectal cancer through eQTL analysis
Adria Closa et al.
CARCINOGENESIS (2014)
Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis
Nicola Whiffin et al.
HUMAN MOLECULAR GENETICS (2014)
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
Sylvia Adams et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches
Felix Dietlein et al.
TRENDS IN GENETICS (2014)
TGF-β Effects on Prostate Cancer Cell Migration and Invasion Are Mediated by PGE2 through Activation of PI3K/AKT/mTOR Pathway
BaoHan T. Vo et al.
ENDOCRINOLOGY (2013)
Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway
Jie Ni et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients
Manuarii Manuel et al.
ONCOIMMUNOLOGY (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
CGG-repeat expansion in the DIP2B gene is associated with the fragile site FRA12A on chromosome 12q13.1
Birgitta Winnepenninckx et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
PI3K/Akt signalling pathway and cancer
JAF Vara et al.
CANCER TREATMENT REVIEWS (2004)
Cloning, genomic organization and expression pattern of a novel Drosophila gene, the disco-interacting protein 2 (dip2), and its murine homolog
M Mukhopadhyay et al.
GENE (2002)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
